| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.922 | 11.985 | 25.597 | 5.636 | 5.854 | 11.179 | 14.646 | 17.521 | 25.978 | 24.088 |
| Total Income - EUR | 8.923 | 11.985 | 25.597 | 5.636 | 5.854 | 11.179 | 14.651 | 28.207 | 29.998 | 24.088 |
| Total Expenses - EUR | 5.030 | 5.286 | 7.664 | 5.383 | 4.407 | 4.916 | 6.396 | 9.710 | 28.339 | 21.333 |
| Gross Profit/Loss - EUR | 3.892 | 6.698 | 17.933 | 252 | 1.447 | 6.263 | 8.255 | 18.497 | 1.659 | 2.755 |
| Net Profit/Loss - EUR | 3.625 | 6.459 | 17.677 | 229 | 1.272 | 5.928 | 7.822 | 17.668 | 1.399 | 2.254 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Qar Clinical Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 185 | 183 | 1.765 | 1.527 | 1.498 | 1.469 | 1.531 | 51.321 | 40.265 | 29.201 |
| Current Assets | 10.771 | 8.433 | 24.241 | 25.482 | 23.101 | 12.996 | 10.886 | 12.122 | 7.643 | 14.007 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 10.551 | 71 | 7.066 | 4.386 | 120 | 97 | 186 | 7.502 | 10 | 66 |
| Cash | 220 | 8.362 | 17.175 | 21.096 | 22.981 | 12.898 | 10.700 | 4.621 | 7.633 | 13.942 |
| Shareholders Funds | 10.409 | 6.513 | 24.080 | 23.867 | 22.857 | 12.030 | 8.733 | 17.716 | 11.482 | 3.694 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 547 | 2.103 | 1.926 | 3.142 | 1.742 | 2.435 | 5.823 | 45.727 | 36.427 | 39.514 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Qar Clinical Research Srl